Our Teams

Top Executives

Chairman-James

James Jie Chui

Chairman

Chief

SHUGENE LYNN, Ph.D.

Chief Executive Officer and President

Chief

CHANG YI WANG, Ph.D.

Chief Scientific Officer

Executive

MEIJUNE LIAO, Ph.D.

Executive Vice President, Product Development

Chief

Keith Lau

Chief Financial Officer and Corporate Secretary

President,

XINGTIAN YAO

President, UBP, Yangzhou

Business advisors from UBI Group

-MEI

MEI MEI HU, JD

-Louis

Louis G. Reese

Scientific Advisors And Clinical Partners

-Carl

Carl V Hanson, Ph.D.

-Jeffery

Jeffery Jacobson, M.D.

-Tae-Wook

Tae-Wook Chun, Ph.D.

-M.

M. D. Lichterfield, M.D., Ph.D.

-Hao

Hao Wu, M.D.

-Chang,

Chang, Tse Wen, Ph.D.

-Anna

Anna Wald, M.D., MPH

-Jeffrey

Jeffrey Cohen, M.D.

-Pamela

Pamela Guerrerio, M.D., Ph.D.

-Tsai

Tsai Hung-Chin M.D., Ph.D.

-Han-Chung

Han-Chung Wu, Ph.D.

Senior Management Team

Senior

Be-Sheng (Ben) Kuo, Ph.D.

Senior Vice President, Preclinical/ ImmunoPharmacology

Vice

Yaw-Jen Liu, Ph.D

Vice President, Research and Development

Vice

Victor Sun

Vice President, Public Affairs and Spokesperson

Vice

AiXiang Zhou (Frieda), Ph.D

Vice President, Manufacturing

Director,

Hsiao-Wen Su, Ph.D

Director, Clinical Development Center

Director,

Vincent Liu

Director, Business Development Division

Director,

Samuel Li

Director, Business Development Division

Board of Directors

-James

James Jie Chui

-Shugene

Shugene Lynn, Ph.D.

Ming-Long

Ming-Long Huang, Director